Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21Cip1/WAF1 and p27Kip1

BackgroundThe signal transducer and activator of transcription 6 (Stat6), a member of the family of DNA-binding proteins, has been identified as a critical cell differentiation modulator in breast cancer cells. As of yet, the mechanisms underlying this function have remained largely unknown. To further elucidate the role of Stat6 in breast cancer development, we investigated the consequences of exogenous Stat6 expression.MethodsProliferation assays and flow cytometry assays were conducted to evaluate the putative role of Stat6 on cell proliferation. To this end, we produced synchronized cells after a double thymidine block, as confirmed by FACS analysis. mRNA levels of Stat6 were measured by RNase protection analysis. To confirm the interaction among proteins, we employed GST pull-down assays and immunoprecipitation assays. Luciferase assays and ChIP assays were used to assess the transcriptional activity.ResultsCompared to control breast cancer cells, we found that exogenous Stat6 expression plays a critical role in controlling cell proliferation. Also in different breast tumor cell lines, endogenous Stat6 expression was found to be positively related to a lower proliferation rate. Interestingly, in human breast cancer cells Stat6 functions in G1/S cell cycle progression, and the growth-inhibitory effect of Stat6 was shown to be mediated by induction of the G1 cyclin-dependent kinase inhibitors p21Cip1/WAF1 (p21) and p27Kip1 (p27). Simultaneously, G1-related cyclin/cyclin-dependent kinase activities and pRB phosphorylation were markedly reduced, and cell cycle progression was blocked in the G1 phase. Stat6 knockdown resulted in enhanced cell proliferation and a decrease in p21 and p27 mRNA levels in the steroid-responsive and non-responsive T-47D and MDA-MB-231 cell lines, respectively. In addition, the stimulatory effect of Stat6 on p21 and p27 gene transcription was found to be associated with interaction of Stat6 with the transcription factor Sp1 at the proximal Sp1-binding sites in their respective promoters.ConclusionsTogether, these results identify Stat6 as an important cell differentiation regulatory protein functioning, at least in part, by interacting with Sp1 to activate the p21 and p27 gene promoters in breast cancer cells.

[1]  J. Wiebe,et al.  Activity and expression of progesterone metabolizing 5α-reductase, 20α-hydroxysteroid oxidoreductase and 3α(β)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells , 2003, BMC Cancer.

[2]  J. Mester,et al.  p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor α , 2005, Molecular and Cellular Biology.

[3]  E. Kieff,et al.  Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II , 2002, The EMBO journal.

[4]  Soo-Jin Jeong,et al.  Penta-O-galloyl-β-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A, P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple-negative xenograft growth , 2010, Breast Cancer Research.

[5]  M. Neurath,et al.  Cutting Edge: IL-12 and IL-18 Differentially Regulate the Transcriptional Activity of the Human IFN-γ Promoter in Primary CD4+ T Lymphocytes , 1998, The Journal of Immunology.

[6]  L. Tian,et al.  Inducible expression of a degradation‐resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells , 2005, FEBS letters.

[7]  W. Koltun,et al.  IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells. , 2008, Cytokine.

[8]  M. Kitagawa,et al.  A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. , 1994, Oncogene.

[9]  A. Lucas,et al.  IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells , 2003, Oncogene.

[10]  Z. Yao,et al.  Coactivator P100 Protein Enhances STAT6‐Dependent Transcriptional Activation But Has No Effect on STAT1‐Mediated Gene Transcription , 2010, Anatomical record.

[11]  E. Solary,et al.  HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S‐phase re‐entry in stressed cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  W. Hung,et al.  Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen. , 2003, Biochemical pharmacology.

[13]  M. Ratnam,et al.  R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism. , 2007, Molecular endocrinology.

[14]  A. Efeyan,et al.  p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. , 2002, Carcinogenesis.

[15]  D. Mann,et al.  Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence , 2001, Oncogene.

[16]  Y. S. Choi,et al.  Identification and activation mechanism of the interleukin-4-induced nuclear factor binding to the CD23(b) promoter in human B lymphocytes. , 1997, Molecules and cells.

[17]  Yingyan Yu,et al.  3b, results in HMBA-induced differentiation of human gastric cancer cells , 2011 .

[18]  Goberdhan P Dimri,et al.  BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer , 2010, Molecular Cancer.

[19]  Yunfeng Zhou,et al.  STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells. , 2006, Cancer letters.

[20]  N. Reich,et al.  Cooperation of the transcriptional coactivators CBP and p300 with Stat6. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[21]  David Steven Scott,et al.  Regulation of the G1 phase of the mammalian cell cycle , 2000, Cell Research.

[22]  G. Jenster,et al.  Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. , 2000, Molecular endocrinology.

[23]  Andrew D Westwell,et al.  Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. , 2005, Current cancer drug targets.

[24]  R. Weinberg,et al.  Increased histone H1 phosphorylation and relaxed chromatin structure in Rb-deficient fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Yee,et al.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. , 2002, Neoplasia.

[26]  C. Anderson,et al.  Caspase 3 and p27 as predictors of invasive bladder cancer. , 2000, The New England journal of medicine.

[27]  M. Knowles,et al.  Mutant Fibroblast Growth Factor Receptor 3 Induces Intracellular Signaling and Cellular Transformation in a Cell Type- and Mutation-Specific Manner , 2009, Oncogene.

[28]  V. Nguyen,et al.  Involvement of STAT-1 and Ets Family Members in Interferon-γ Induction of CD40 Transcription in Microglia/Macrophages* , 2000, The Journal of Biological Chemistry.

[29]  G. Woodfield,et al.  TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. , 2007, Cancer research.

[30]  N. Shao,et al.  The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter , 1999, Oncogene.

[31]  E. Schmitt,et al.  IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. , 1998, Journal of immunology.

[32]  T. Sakai,et al.  Molecular cloning and characterization of the human p27Kip1 gene promoter 1 , 1997, FEBS letters.

[33]  R. Sutherland,et al.  Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2* , 2001, The Journal of Biological Chemistry.

[34]  Jeff Hasty,et al.  Engineered gene circuits , 2002, Nature.

[35]  R. Sutherland,et al.  Inducible expression of cyclin D1 in T‐47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation , 1996, Journal of cellular biochemistry.

[36]  R. A. Hunt,et al.  Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy. , 2000, Hypertension.

[37]  T. Shimosegawa,et al.  Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[38]  R. Tekmal,et al.  Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy , 2011, Steroids.

[39]  Jun-ichi Iwata,et al.  Role of the transcription factor Sp1 in regulating the expression of the murine cathepsin E gene. , 2012, Journal of biochemistry.

[40]  S. Ebong,et al.  Cell Proliferation and STAT6 Pathways Are Negatively Regulated in T Cells by STAT1 and Suppressors of Cytokine Signaling , 2004, The Journal of Immunology.

[41]  I. Weinstein,et al.  Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1. , 2008, Cancer research.

[42]  G. Mellgren,et al.  The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. , 2002, Molecular endocrinology.

[43]  X. Le,et al.  Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. , 2008, Cancer research.

[44]  M. Kaplan,et al.  Stat Proteins Control Lymphocyte Proliferation by Regulating p27Kip1 Expression , 1998, Molecular and Cellular Biology.

[45]  J. Rosen,et al.  The Dynamic Mobility of Histone H1 Is Regulated by Cyclin/CDK Phosphorylation , 2003, Molecular and Cellular Biology.

[46]  D. Harrison,et al.  Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFβ cell cycle arrest , 2007, BMC Cancer.

[47]  C. Keck,et al.  Localization of the human stat6 gene to chromosome 12q13.3-q14.1, a region implicated in multiple solid tumors. , 1998, Genomics.

[48]  N. Acharya,et al.  Novel anticancer agents from plant sources , 2013 .

[49]  M. Boothby,et al.  Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation. , 1999, Journal of immunology.

[50]  Y. Qu,et al.  Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation , 2008, Journal of Cancer Research and Clinical Oncology.

[51]  J. Nesland,et al.  Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients , 1999, Virchows Archiv.

[52]  X. Qin,et al.  Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor. , 2007, Biochemical and biophysical research communications.

[53]  Pei-Chen Hsieh,et al.  p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates β-catenin pathway , 2007, Oncogene.

[54]  Yingyan Yu,et al.  A Novel Plant Homeodomain Finger 10–Mediated Antiapoptotic Mechanism Involving Repression of Caspase-3 in Gastric Cancer Cells , 2010, Molecular Cancer Therapeutics.

[55]  D. Templeton,et al.  The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity , 1997, Oncogene.

[56]  Y. Zhou,et al.  NG 2 , a novel proapoptotic receptor , opposes integrin a 4 to mediate anoikis through PKC a-dependent suppression of FAK phosphorylation , 2008 .

[57]  G. Barnett,et al.  Anti-sense oligonucleotide of p21(waf1/cip1) prevents Interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells , 2000, Oncogene.

[58]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[59]  S. Paternot,et al.  Distinct Specificities of pRb Phosphorylation by CDK4 Activated by Cyclin D1 or Cyclin D3: Differential Involvement in the Distinct Mitogenic Modes of Thyroid Epithelial Cells , 2006, Cell cycle.

[60]  Adam G. Diehl,et al.  Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. , 2011, Molecular endocrinology.

[61]  J. Coebergh,et al.  An overview of prognostic factors for long-term survivors of breast cancer , 2007, Breast Cancer Research and Treatment.

[62]  Jian Gu,et al.  Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer , 2008, Cancer.

[63]  S. Mani,et al.  Cyclin-dependent kinase inhibitors: novel anticancer agents , 2000, Expert opinion on investigational drugs.

[64]  M. Summers,et al.  The structural protein ODV-EC27 of Autographa californica nucleopolyhedrovirus is a multifunctional viral cyclin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Stütz,et al.  The Th2 Cell Cytokines IL-4 and IL-13 Regulate Found in Inflammatory Zone 1/Resistin-Like Molecule α Gene Expression by a STAT6 and CCAAT/Enhancer-Binding Protein-Dependent Mechanism , 2003, The Journal of Immunology.

[66]  P. Mäenpää,et al.  Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein. , 2003, Biochemical pharmacology.

[67]  K. Horwitz,et al.  Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). , 1997, Molecular endocrinology.

[68]  R. Sutherland,et al.  Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation , 2008, Oncogene.

[69]  Zhenggang Zhu,et al.  Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model , 2011, Cancer science.

[70]  J. Carroll,et al.  Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells. , 2002, Cancer research.

[71]  Yingyan Yu,et al.  P27Kip1, regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells , 2011, BMC Cancer.

[72]  A. Valledor,et al.  IL‐4 blocks M‐CSF‐dependent macrophage proliferation by inducing p21Waf1 in a STAT6‐dependent way , 2009, European journal of immunology.